Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 12
Original Research
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,236 | Dovepress* | 6,787+ | 1,287 | 8,074 | |
| PubMed Central* | 1,449 | 328 | 1,777 | ||
| Totals | 8,236 | 1,615 | 9,851 | ||
| *Since 15 April 2020 | |||||
View citations on PubMed Central and Google Scholar